Nature Reviews Neuroscience (2018) https://doi.org/10.1038/s41583-018-0055-7 Published online 11 September 2018
In the originally published version of this article, the competing interests statement indicated that the authors had no competing interests; however, this statement was incorrect. The statement should have read as follows: ‘M.H. receives a consultation fee from IFM Therapeutics, LLC for consultations regarding the pathogenesis and interventional strategies of neurodegenerative disease. E.L. is a scientific co-founder and consultant to IFM Therapeutics. R.M.M. declares no competing interests.’ This error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heneka, M.T., McManus, R.M. & Latz, E. Author Correction: Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 20, 187 (2019). https://doi.org/10.1038/s41583-019-0137-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41583-019-0137-1
This article is cited by
-
Scoparone suppresses mitophagy-mediated NLRP3 inflammasome activation in inflammatory diseases
Acta Pharmacologica Sinica (2023)